Stockscreener 앱 받기
0.8245
0.19%
0.0016
시간 외 거래:
.81
-0.0145
-1.76%
Biofrontera Inc 주식(BFRI)의 최신 뉴스
How Biofrontera Inc. Equity Warrant stock benefits from tech adoptionQuarterly Growth Report & Fast Exit and Entry Strategy Plans - ulpravda.ru
Can Biofrontera Inc. Equity Warrant stock deliver strong Q4 earningsWeekly Profit Summary & Community Consensus Trade Signals - ulpravda.ru
What Wall Street predicts for Biofrontera Inc. stock priceQuarterly Market Summary & Low Drawdown Investment Ideas - ulpravda.ru
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones - Sahm
Can Biofrontera Inc. Equity Warrant stock maintain growth trajectoryQuarterly Performance Summary & Real-Time Market Sentiment Reports - ulpravda.ru
Will Biofrontera Inc. stock outperform Nasdaq indexWeekly Gains Summary & Smart Swing Trading Alerts - ulpravda.ru
Can Biofrontera Inc. Equity Warrant stock outperform in 2025 bull marketPortfolio Performance Report & Fast Gain Stock Trading Tips - ulpravda.ru
Will Biofrontera Inc. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Selloffs & Weekly Market Pulse Updates - ulpravda.ru
Is Biofrontera Inc. Equity Warrant stock cheap at current valuationTrade Volume Summary & Daily Oversold Bounce Ideas - ulpravda.ru
Is Biofrontera Inc. Equity Warrant stock a safe haven assetJuly 2025 Trends & Weekly Watchlist for Consistent Profits - ulpravda.ru
Biofrontera reaches database lock milestone for skin treatment studies By Investing.com - Investing.com Australia
Will Biofrontera Inc. (AI10) stock outperform value peersMarket Trend Report & AI Enhanced Trade Execution Alerts - ulpravda.ru
Why Biofrontera Inc. (AI10) stock remains stableTake Profit & Accurate Entry/Exit Alerts - ulpravda.ru
Is Biofrontera Inc. Equity Warrant stock affected by interest rate hikesInflation Watch & High Conviction Buy Zone Alerts - ulpravda.ru
Biofrontera reaches database lock milestone for skin treatment studies - Investing.com
Biofrontera announces data base locks for two clinical studies - TipRanks
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval - MSN
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance - TipRanks
Biofrontera Received Notice of Noncompliance - TradingView — Track All Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Sahm
Guidance Update: Can Biofrontera Inc Equity Warrant stock maintain growth trajectoryWeekly Earnings Recap & Growth Oriented Trading Recommendations - moha.gov.vn
Aug Summary: How resilient is Biofrontera Inc Equity Warrant stock in market downturnsAnalyst Upgrade & Free Accurate Trade Setup Notifications - moha.gov.vn
Retail Trends: Will Biofrontera Inc. stock split again soonJuly 2025 Summary & Weekly Top Gainers Alerts - Улправда
Is Biofrontera Inc. stock a top momentum playMarket Risk Report & Expert Verified Movement Alerts - Улправда
Will Biofrontera Inc. stock split again soonMarket Activity Report & Accurate Trade Setup Notifications - Улправда
How interest rate cuts could boost Biofrontera Inc. Equity Warrant stockGlobal Markets & AI Driven Stock Reports - Улправда
Will Biofrontera Inc. stock reach all time highs in 2025Profit Target & Long Hold Capital Preservation Plans - Улправда
Why Biofrontera Inc. stock remains resilientInflation Watch & Verified Swing Trading Watchlists - Улправда
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED By Investing.com - Investing.com South Africa
How Biofrontera Inc. stock reacts to global recession fearsGold Moves & Expert Curated Trade Setups - Улправда
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED - Investing.com
Biofrontera completes transfer of Ameluz® and Rhodoled® FDA approval - marketscreener.com
Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio - The Manila Times
Biofrontera Inc. Completes Transfer of Ameluz® and - GlobeNewswire
Book value per share of Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera – NASDAQ:BFRIW - TradingView — Track All Markets
Aug Levels: Will Biofrontera Inc Equity Warrant stock split attract more investorsPortfolio Performance Summary & AI Enhanced Trading Alerts - moha.gov.vn
What analysts say about Biofrontera Inc AI10 stockContrarian Investment Ideas & Free Daily Top Stock Picks for All Investors - earlytimes.in
Biofrontera (NASDAQ:BFRI) Trading Down 1.5% – Time to Sell? - Defense World
Biofrontera Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Biofrontera completes phase 1 study for expanded Ameluz treatment areas By Investing.com - Investing.com Nigeria
Will Biofrontera Inc. (AI10) stock sustain bullish trend into 2025Market Growth Review & Risk Controlled Swing Alerts - Newser
Why Biofrontera Inc. (AI10) stock attracts HNW investors2025 Big Picture & Safe Entry Momentum Tips - Newser
Why Biofrontera Inc. (AI10) stock is favored by hedge fundsWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - Newser
Will Biofrontera Inc. Equity Warrant stock outperform growth indexes2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel - TipRanks
Biofrontera completes phase 1 study for expanded Ameluz treatment areas - Investing.com
0.37%
1.55%
자본화:
|
볼륨(24시간):